logo

For the Inventor, By the Inventor

Xi'an, China

Qianqian Zhao

This inventor holds 25 USPTO granted patents, primarily in Antibiotic Resistance. Top assignees: Shaanxi University of Science and Technology, Xi'an Kangyuansheng Biomedical Technology Co., Ltd., Xi'an Taikomed Pharmaceutical Technology Co., Ltd.. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qianqian Zhao. Retrieved from https://idiyas.com/inventor/qianqian-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 48.0

Average Co-Inventor Count = 11.2

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Xi+3 an, CN (2022 - 2023)
  • Xi'an, CN (2019 - 2024)

Company Filing History:

goldMedal21 out of 109 
 
Shaanxi University of Science and Technology
 patents
silverMedal2 out of 3 
 
Xi'an Kangyuansheng Biomedical Technology Co., Ltd.
 patents
bronzeMedal2 out of 9 
 
Xi'an Taikomed Pharmaceutical Technology Co., Ltd.
 patents

Years Active: 2019-2024

Loading Chart...
Areas of Expertise:
Pleuromutilin
Antibiotic Resistance
Antibacterial Activity
Silibinin
Hydroxytyrosol
Antioxidant Activity
Hepatoprotective
Cinnamic Acid
Acid Esters
Herbal Medicine Extraction
Cardiovascular Diseases
Lipoic Acid
25 patents (USPTO):Explore Patents
1. 11872202 - Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections (2024-01-16),
2. 11712457 - seed extract composition and its application in antibiotic-resistant infections (2023-08-01),
3. 11597714 - Pleuromulin lipoic acid ester with antibacterial activity and a method of preparing the same (2023-03-07),
4. 11518740 - Pleuromutilin (phenylthio)acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-12-06),
5. 11512049 - Pleuromutilin 2-[(diphenylmethyl)thio] acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-29),
6. 11510905 - Pleuromutilin (E)-4-(1-imidazoylmethyl)cinnamic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-29),
7. 11484598 - Pleuromulin rhein ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-01),
8. 11401233 - Pleuromutilin salicylic acid ester with antibacterial activity and a method of preparing the same (2022-08-02),
9. 11376299 - Lilac ginkgo brick tea and method of preparing the same (2022-07-05),
10. 11306076 - Silibinin lipoic acid ester with hepatoprotective activity and a method of preparing the same (2022-04-19),
11. 11186607 - Pleuromutilin ursodeoxycholic acid ester with antibacterial activity and a method of preparing the same (2021-11-30),
12. 11117859 - Pleuromutilin hippuric acid ester with antibacterial activity and a method of preparing the same (2021-09-14),
13. 10995053 - Hydroxytyrosol ursolic acid ester with antioxidant activity and methods of preparing the same (2021-05-04),
14. 10941120 - 6-aminouracil cassic acid ester with antibacterial activity and a method of preparing the same (2021-03-09),
15. 10836703 - Hydroxytyrosol acitretin ester with antioxidant activity and a method of preparing the same (2020-11-17),

Title: **Qianqian Zhao: Innovator in Antibiotic-Resistant Infections**

Introduction

Qianqian Zhao is an esteemed inventor based in Xi'an, China, with a remarkable portfolio of 25 patents. His innovative contributions primarily focus on combating antibiotic-resistant infections, which is a critical area of healthcare research.

Latest Patents

Among his latest patents, Zhao has developed pleuromutilin cinnamic acid ester compounds that have significant activity against antibiotic-resistant infections. This compound is designed with a versatile formula, allowing various chemical groups to be integrated, which enhances its efficacy. Furthermore, Zhao has patented a seed extract composition aimed at treating antibiotic-resistant infections. This composition includes essential components such as echinacoside and oleuropein, and outlines a method for preparing the seed extract, demonstrating its potential in pharmaceutical applications.

Career Highlights

Qianqian Zhao has made substantial strides in his career, holding positions at reputable institutions like Shaanxi University of Science and Technology and Xi'an Taikomed Pharmaceutical Technology Co., Ltd. His work at these organizations has allowed him to drive research initiatives and develop groundbreaking solutions in antibiotic resistance.

Collaborations

Throughout his career, Zhao has collaborated with notable researchers, including Han Li and Chengyuan Liang. These partnerships have further enriched his innovative endeavors, leading to the significant advancements in treatment methodologies for antibiotic-resistant infections.

Conclusion

Qianqian Zhao continues to be a prominent figure in the field of pharmaceutical innovation, particularly in addressing the urgent issue of antibiotic resistance. His extensive patent portfolio and collaborative initiatives demonstrate his commitment to advancing medical science and improving health outcomes globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…